Acetylation at lysine 4 (K4) of H3, identified particularly in promoter regions of genes involved in the estrogen receptor signaling pathway, regulates their expression and is implicated in the progression of luminal breast cancer [50]. This evidence concerns the gene ESR1 and breast cancer.